Changes in thrombocytes under adriamycin therapy
Ruzicka, F.; Böhnel, J.; Fierkens, B.; Grohs, H.; Stacher, A.
Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 5(3): 345-351
1971
ISSN/ISBN: 0020-9392 PMID: 5148891 Document Number: 37810
Document emailed within 1 workday
Related Documents
Hoshino, M.; Koyama, Y.; Sugano, K.; Kanno, M.; Satou, N.; Abe, R. 1989: Enhanced effect of hepatic arterial infused anticancer drugs on rabbit VX-2 carcinoma by means of combination with Lipiodol. Adriamycin versus Lipiodol adriamycin sandwich method and adriamycin suspended in a Lipiodol Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(8 Part 2): 2810-2813Kinoshita, N.; Tochigi, H.; Yanagawa, M.; Yamakawa, K.; Sakurai, M.; Hioki, T.; Kawamura, J. 1990: Clinical study of intravesical instillation therapy of superficial bladder tumor--combination therapy of mitomycin C, adriamycin, peplomycin and cytosine arabinoside Hinyokika Kiyo. Acta Urologica Japonica 36(3): 257-263
Paar, D. 1972: Behavior of thrombocytes under immunosuppressive and anticoagulant therapy in a case of thrombophlebitis migrans Die Medizinische Welt 23(45): 1666-1667
Burduli, N.M.; Gutnova, S.K. 2006: The influence of low-intensive laser therapy on the aggregation properties of thrombocytes in patients with peptic ulcer Klinicheskaia Meditsina 84(2): 61-64
Asaumi, J.; Kawasaki, S.; Nishikawa, K.; Kuroda, M.; Takeda, Y.; Hiraki, Y. 1996: FK506 completely inhibits adriamycin efflux in the adriamycin-resistant strain of Ehrlich ascites tumor cells Anticancer Research 16(1): 247-250
Adam, Z.; Elbl, L.; Vorlícek, J.; Hájek, R.; Tomíska, M.; Hejlová, N.; Králová, E.; Novotná, H. 1994: Lower cardiotoxicity of adriamycin during continuous administration in patients with refractory multiple myeloma treated with cyclophosphamide, vincristine, adriamycin and dexamethasone (C-VAD) Vnitrni Lekarstvi 40(8): 506-512
Choudhury, A.R.; Friederichs, E.; Speer, C.P.; Schröter, W. 1989: Neonatal alloimmunothrombocytopenia--effect of combination therapy consisting of I.v. immunoglobulin administration and transfusion of PLA1-negative maternal thrombocytes Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 137(8): 458-462
Goldenberg, G.J.; Wang, H.; Blair, G.W. 1986: Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia Cancer Research 46(6): 2978-2983
Herman, T.S.; Jones, S.E.; McMahon, L.J.; Lloyd, R.E.; Heusinkveld, R.S.; Miller, R.C.; Salmon, S.E. 1977: Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung Cancer Treatment Reports 61(5): 875-879
Deffie, A.M.; Alam, T.; Seneviratne, C.; Beenken, S.W.; Batra, J.K.; Shea, T.C.; Henner, W.D.; Goldenberg, G.J. 1988: Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia Cancer Research 48(13): 3595-3602
Hu, Y.S. 1993: Peripheral adriamycin injection for therapy of idiopathic trigeminal neuralgia: 42 cases report Zhonghua Kou Qiang Yi Xue Za Zhi 28(5): 281-3 319
Sulkes, A.; Uziely, B.; Isacson, R.; Brufman, G.; Biran, S. 1988: Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas Israel Journal of Medical Sciences 24(9-10): 604-610
Cesano, A.; Visonneau, S.; Rovera, G.; Santoli, D. 1997: Synergistic effects of adriamycin and TALL-104 cell therapy against a human gastric carcinoma in vivo Anticancer Research 17(3c): 1887-1892
Abeloff, M.D.; Ettinger, D.S. 1977: Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy Cancer Treatment Reports 61(9): 1685-1689
Tokunaga, A.; Onda, M.; Mizutani, T.; Miyamoto, M.; Nomura, T.; Hayashi, H.; Kiyama, T.; Umehara, M.; Nishi, K.; Andoh, T. 1989: Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(12): 3713-3718
Wada, N.; Kobayashi, H.; Oka, S.; Ando, J.; Tamura, H. 2002: Combined chemoendocrine therapy using adriamycin, cyclophosphamide and high dose toremifene in patients with recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(11): 1935-1942
Katakkar, S.B.; Franks, C.R. 1978: Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate Cancer Treatment Reports 62(9): 1379-1380
Lehnert, M.; Biffl, G.; Wascher, H.; Jordis-Lohausen, K.; Wählby, S. 1986: A preliminary analysis of combination therapy with vincristine, adriamycin, and prednimustine (VAP) in advanced breast cancer: a phase Ii study Seminars in Oncology 13(1 Suppl 1: 32-34
Eagan, R.T.; Lee, R.E.; Frytak, S.; Scott, M.; Ingle, J.N.; Creagan, E.T.; Nichols, W.C. 1981: Thoracic radiation therapy and Adriamycin/cisplatin-containing chemotherapy for locally advanced non-small-cell lung cancer Cancer Clinical Trials 4(4): 381-388
McMahon, L.J.; Herman, T.S.; Manning, M.R.; Dean, J.C. 1979: Patterns of relapse in patients with small cell carcinoma of the lung treated with adriamycin-cyclophosphamide chemotherapy and radiation therapy Cancer Treatment Reports 63(3): 359-362